08/13/2024 3:12 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 3:19 PM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024 3:17 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:19 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:36 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:38 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/19/2024 4:39 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:41 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:42 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:04 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:06 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:07 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 5:56 AM | Immunovant (Filer)
| Form DEF 14A | |
06/26/2024 6:01 AM | Immunovant (Filer)
| Form DEFA14A | |
05/29/2024 3:36 PM | Immunovant (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/26/2024 4:22 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:57 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:59 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:01 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:05 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:06 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:18 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:14 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:16 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:54 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:31 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:34 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:37 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:39 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:44 PM | Immunovant (Issuer) Torti Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:46 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:48 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:50 PM | Hughes Douglas J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:23 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:29 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:14 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Millionaire Investor Warns: “Brace for Apple Collapse” (Ad) Apple stock has quadrupled over the past five years.
But now even Warren Buffett is pulling the plug. The Oracle of Omaha just sold HALF his stake – worth more than $75 billion in the iconic tech company.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9161&Placement=NativeDisplay&Source=NativeDisplay) To watch his fascinating interview which has taken Wall Street by storm, click here. |
02/23/2024 3:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:21 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 AM | Deep Track Capital, LP (Filed by) Immunovant (Subject)
| Form SC 13G/A | |
02/12/2024 6:02 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:05 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/09/2024 8:16 AM | Immunovant (Subject)
| Form SC 13G | |
01/19/2024 3:04 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:29 AM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/12/2024 3:34 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:18 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:20 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:08 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:37 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:25 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:28 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:30 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:19 PM | Immunovant (Subject) MIGAUSKY GEORGE V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:19 PM | Fromkin Andrew J. (Reporting) Immunovant (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:20 PM | Immunovant (Subject) Pande Atul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023 6:43 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 1:55 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:45 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:47 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:51 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:41 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 7:49 AM | Immunovant (Filer)
| Form S-3ASR | |
11/09/2023 6:06 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:13 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023 3:06 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 3:11 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:10 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:15 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:15 PM | Immunovant (Issuer) Roivant Sciences Ltd. (Reporting) Roivant Sciences Ltd. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:19 PM | Immunovant (Subject) Roivant Sciences Ltd. (Filed by) Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A | |
09/29/2023 3:48 PM | Immunovant (Filer)
| Form 424B5 | |
09/28/2023 4:23 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 5:09 AM | Immunovant (Subject)
| Form FWP | |
09/26/2023 7:00 PM | Immunovant (Subject)
| Form FWP | |
09/26/2023 4:28 PM | Immunovant (Filer)
| Form 424B5 | |
09/26/2023 6:45 AM | Immunovant (Filer) Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:00 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:03 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:05 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:57 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:48 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 3:11 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |